Compare AbCellera Biologics Inc (ABCL) vs Banco Bilbao Vizcaya Argentaria SA (BBVA) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AbCellera Biologics Inc vs Banco Bilbao Vizcaya Argentaria SA — how do they compare? AbCellera Biologics Inc trades at $7.2 (market cap $2.35B), while Banco Bilbao Vizcaya Argentaria SA trades at $25.3 (market cap $143.90B). The key difference: Banco Bilbao Vizcaya Argentaria SA is far larger — about 61.2× AbCellera Biologics Inc's market cap, and Banco Bilbao Vizcaya Argentaria SA pays a 4.13% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | BBVA | |
|---|---|---|
Market Cap | $2.35B | $143.90B |
Sector | Health | Financials |
52-Week High | $8.12 | $26.14 |
52-Week Low | $2.78 | $14.73 |
Enterprise Value | $1.99B | — |
Dividend Yield | — | 4.13% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AbCellera Biologics (ABCL) trades at $7.69, down 2.29% on the day, with strong analyst support (82% buy ratings) and a $9.67 consensus price target suggesting 26% upside. The stock shows bullish technical momentum with moving averages supporting the trend, though RSI levels indicate potential overbought conditions. Recent positive developments include a major $876 million collaboration with Jazz Pharmaceuticals and board expansions, offsetting concerns about negative cash flow and profitability metrics.
While ABCL faces significant fundamental challenges with negative margins and cash burn, the company's strong cash position ($626M) and recent strategic partnerships provide runway for growth. The primary investment thesis hinges on successful pipeline development and platform monetization, with risks centered on execution and path to profitability. Wall Street remains optimistic about the long-term platform value despite near-term financial headwinds.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Banco Bilbao Vizcaya Argentaria SA
Despite its Spanish origins, BBVA generates three quarters of its profits in emerging markets, especially Mexico that contributes nearly half of BBVA's net profit. BBVA is overwhelmingly a retail and commercial bank with corporate and investment banking forming a smaller part of the overall business.
Read more on BBVA →
